CSTL Annual EBIT
-$57.35 M
+$11.53 M+16.74%
31 December 2023
Summary:
As of January 22, 2025, CSTL annual earnings before interest & taxes is -$57.35 million, with the most recent change of +$11.53 million (+16.74%) on December 31, 2023. During the last 3 years, it has fallen by -$49.79 million (-658.05%). CSTL annual EBIT is now -678.17% below its all-time high of $10.28 million.CSTL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Quarterly EBIT
$8.48 M
+$327.00 K+4.01%
30 September 2024
Summary:
As of January 22, 2025, CSTL quarterly earnings before interest & taxes is $8.48 million, with the most recent change of +$327.00 thousand (+4.01%) on September 30, 2024. Over the past year, it has increased by +$11.02 million (+434.11%). CSTL quarterly EBIT is now at all-time high.CSTL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL TTM EBIT
$11.63 M
+$15.35 M+411.75%
30 September 2024
Summary:
As of January 22, 2025, CSTL TTM earnings before interest & taxes is $11.63 million, with the most recent change of +$15.35 million (+411.75%) on September 30, 2024. Over the past year, it has increased by +$68.98 million (+120.27%). CSTL TTM EBIT is now at all-time high.CSTL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +16.7% | +434.1% | +120.3% |
3 y3 years | -658.0% | +434.1% | +120.3% |
5 y5 years | -1304.4% | +434.1% | +120.3% |
CSTL EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -43.4% | +16.7% | at high | +129.1% | at high | +113.1% |
5 y | 5-year | -678.2% | +16.7% | at high | +129.1% | at high | +113.1% |
alltime | all time | -678.2% | +16.7% | at high | +129.1% | at high | +113.1% |
Castle Biosciences EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $8.48 M(+4.0%) | $11.63 M(-411.7%) |
June 2024 | - | $8.16 M(-429.5%) | -$3.73 M(-87.8%) |
Mar 2024 | - | -$2.48 M(-2.5%) | -$30.64 M(-46.6%) |
Dec 2023 | -$57.35 M(-16.7%) | -$2.54 M(-63.0%) | -$57.35 M(-23.9%) |
Sept 2023 | - | -$6.87 M(-63.4%) | -$75.37 M(-15.1%) |
June 2023 | - | -$18.76 M(-35.7%) | -$88.74 M(+20.6%) |
Mar 2023 | - | -$29.19 M(+42.0%) | -$73.59 M(+6.8%) |
Dec 2022 | -$68.89 M(+72.2%) | -$20.56 M(+1.6%) | -$68.89 M(+8.5%) |
Sept 2022 | - | -$20.24 M(+462.1%) | -$63.48 M(+15.4%) |
June 2022 | - | -$3.60 M(-85.3%) | -$55.03 M(-8.6%) |
Mar 2022 | - | -$24.49 M(+61.6%) | -$60.22 M(+50.5%) |
Dec 2021 | -$40.01 M | -$15.15 M(+28.5%) | -$40.01 M(+36.7%) |
Sept 2021 | - | -$11.79 M(+34.2%) | -$29.27 M(+37.0%) |
June 2021 | - | -$8.79 M(+105.3%) | -$21.36 M(+62.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | -$4.28 M(-2.9%) | -$13.18 M(+74.2%) |
Dec 2020 | -$7.57 M(-176.3%) | -$4.41 M(+13.6%) | -$7.57 M(+2776.8%) |
Sept 2020 | - | -$3.88 M(+539.7%) | -$263.00 K(-102.5%) |
June 2020 | - | -$607.00 K(-145.5%) | $10.56 M(-8.9%) |
Mar 2020 | - | $1.33 M(-53.9%) | $11.59 M(+16.8%) |
Dec 2019 | $9.92 M(-342.9%) | $2.89 M(-58.3%) | $9.92 M(-14.1%) |
Sept 2019 | - | $6.94 M(+1536.1%) | $11.55 M(+565.5%) |
June 2019 | - | $424.00 K(-226.9%) | $1.74 M(-231.8%) |
Mar 2019 | - | -$334.00 K(-107.4%) | -$1.32 M(-67.7%) |
Dec 2018 | -$4.08 M(-61.9%) | $4.53 M(-257.1%) | -$4.08 M(-52.6%) |
Sept 2018 | - | -$2.88 M(+9.6%) | -$8.61 M(+50.3%) |
June 2018 | - | -$2.63 M(-15.2%) | -$5.73 M(+84.8%) |
Mar 2018 | - | -$3.10 M | -$3.10 M |
Dec 2017 | -$10.71 M | - | - |
FAQ
- What is Castle Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Castle Biosciences?
- What is Castle Biosciences annual EBIT year-on-year change?
- What is Castle Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Castle Biosciences?
- What is Castle Biosciences quarterly EBIT year-on-year change?
- What is Castle Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Castle Biosciences?
- What is Castle Biosciences TTM EBIT year-on-year change?
What is Castle Biosciences annual earnings before interest & taxes?
The current annual EBIT of CSTL is -$57.35 M
What is the all time high annual EBIT for Castle Biosciences?
Castle Biosciences all-time high annual earnings before interest & taxes is $10.28 M
What is Castle Biosciences annual EBIT year-on-year change?
Over the past year, CSTL annual earnings before interest & taxes has changed by +$11.53 M (+16.74%)
What is Castle Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of CSTL is $8.48 M
What is the all time high quarterly EBIT for Castle Biosciences?
Castle Biosciences all-time high quarterly earnings before interest & taxes is $8.48 M
What is Castle Biosciences quarterly EBIT year-on-year change?
Over the past year, CSTL quarterly earnings before interest & taxes has changed by +$11.02 M (+434.11%)
What is Castle Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of CSTL is $11.63 M
What is the all time high TTM EBIT for Castle Biosciences?
Castle Biosciences all-time high TTM earnings before interest & taxes is $11.63 M
What is Castle Biosciences TTM EBIT year-on-year change?
Over the past year, CSTL TTM earnings before interest & taxes has changed by +$68.98 M (+120.27%)